Literature DB >> 2541259

Mechanisms of cellular invasiveness: a comparison of amnion invasion in vitro and metastatic behavior in vivo.

S Yagel1, R Khokha, D T Denhardt, R S Kerbel, R S Parhar, P K Lala.   

Abstract

We employed a sensitive in vitro amnion invasion assay to examine the relationship of the invasive ability of numerous mouse and human tumor cell lines and their variants to their ability to spontaneously or artificially metastasize; we also studied possible enzymatic activities involved in the in vitro invasion process. In vitro invasive ability of tumor cells was strongly correlated with spontaneous metastatic ability from the subcutaneous site, regardless of the ability of tumor cells to form artificial metastases when introduced intravenously. However, normal nontumorigenic human trophoblast cells were also highly invasive. Various collagenase inhibitors totally abrogated amnion penetration by all invasive cells; various inhibitors of plasmin, plasminogen, and plasminogen activators prevented invasion in most, but not all, cases. Thus, amnion penetration provides a rigorous test for tumor cell invasiveness required for spontaneous metastasis in vivo, and invasiveness is strongly dependent on metalloproteinase activity, which usually follows plasmin activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541259     DOI: 10.1093/jnci/81.10.768

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  11 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

Review 2.  The role of tissue inhibitor of metalloproteinase-1 in specific aspects of cancer progression and reproduction.

Authors:  R Khokha; P Waterhouse
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

3.  Basement membrane invasion by first trimester human trophoblast: requirement for branched complex-type Asn-linked oligosaccharides.

Authors:  S Yagel; R Kerbel; P Lala; T Eldar-Gera; J W Dennis
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

4.  Increased proteinase expression during tumor progression of cell lines down-modulated for TIMP levels: a new transformation paradigm? [corrected].

Authors:  R Khokha; P Waterhouse; P Lala; M Zimmer; D T Denhardt; R Khokka
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 5.  Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors.

Authors:  P K Lala; C H Graham
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

6.  An Eastern Cooperative Oncology Group phase I trial of all-trans-retinoic acid and interferon-alpha: E2Y92.

Authors:  J H Schiller; D Neuberg; D Burns; P Ritch; M Larson; M Levitt; J Dutcher
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

7.  Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line.

Authors:  I Sunitha; D L Meighen; D P Hartman; E W Thompson; S W Byers; M I Avigan
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

8.  Human skin in organ culture. Elaboration of proteolytic enzymes in the presence and absence of exogenous growth factors.

Authors:  J Varani; P Perone; D R Inman; W Burmeister; S B Schollenberger; S E Fligiel; R G Sitrin; K J Johnson
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

9.  Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasion.

Authors:  R D Bonfil; P A Medina; D E Gómez; E Farías; A Lazarowski; M F Lucero Gritti; R P Meiss; O D Bustuoabad
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

10.  Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

Authors:  D Foucré; C Bouchet; K Hacène; N Pourreau-Schneider; A Gentile; P M Martin; A Desplaces; J Oglobine
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.